Barry V.l. PotterMA, DPhil, DSc, CSci, CBiol, FRSB, FIoD, CChem, FRSC, FMedSci
Professor Barry Potter was Head of Medicinal Chemistry at the University of Bath for over 20 years and has brought academically-discovered drugs to multiple clinical trials and co-founded a spin-out biotech company acquired by Big Pharma, where he was a board director and Chief Scientific Officer. He also worked for many years in a formal academic-pharma industry drug discovery partnership.
He is Professor of Medicinal & Biological Chemistry at Oxford University and a Fellow of University College Oxford. He serves on numerous editorial boards and has published over 550 papers in synthetic chemistry applied to Biology & Medicine.